DK2924053T3 - Glycosyleret linker, forbindelse, der indeholder glycosyleret linker-del og fysiologisk aktiv stofdel eller salt deraf, og fremgangsmåder til fremstilling af forbindelsen eller saltet deraf - Google Patents

Glycosyleret linker, forbindelse, der indeholder glycosyleret linker-del og fysiologisk aktiv stofdel eller salt deraf, og fremgangsmåder til fremstilling af forbindelsen eller saltet deraf Download PDF

Info

Publication number
DK2924053T3
DK2924053T3 DK13857593.1T DK13857593T DK2924053T3 DK 2924053 T3 DK2924053 T3 DK 2924053T3 DK 13857593 T DK13857593 T DK 13857593T DK 2924053 T3 DK2924053 T3 DK 2924053T3
Authority
DK
Denmark
Prior art keywords
links
glycosyled
glycosylated
salts
preparation
Prior art date
Application number
DK13857593.1T
Other languages
Danish (da)
English (en)
Inventor
Hirofumi Ochiai
Kenta Yoshida
Original Assignee
Glytech Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glytech Inc filed Critical Glytech Inc
Application granted granted Critical
Publication of DK2924053T3 publication Critical patent/DK2924053T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K17/00—Carrier-bound or immobilised peptides; Preparation thereof
    • C07K17/02—Peptides being immobilised on, or in, an organic carrier
    • C07K17/10—Peptides being immobilised on, or in, an organic carrier the carrier being a carbohydrate
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/54—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound
    • A61K47/549—Sugars, nucleosides, nucleotides or nucleic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08H—DERIVATIVES OF NATURAL MACROMOLECULAR COMPOUNDS
    • C08H1/00—Macromolecular products derived from proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/62—Medicinal preparations containing antigens or antibodies characterised by the link between antigen and carrier
    • A61K2039/627—Medicinal preparations containing antigens or antibodies characterised by the link between antigen and carrier characterised by the linker
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Biochemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Materials Engineering (AREA)
  • Polymers & Plastics (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Peptides Or Proteins (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Toxicology (AREA)
  • Inorganic Chemistry (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Saccharide Compounds (AREA)
DK13857593.1T 2012-11-22 2013-10-30 Glycosyleret linker, forbindelse, der indeholder glycosyleret linker-del og fysiologisk aktiv stofdel eller salt deraf, og fremgangsmåder til fremstilling af forbindelsen eller saltet deraf DK2924053T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2012256947 2012-11-22
PCT/JP2013/079408 WO2014080730A1 (fr) 2012-11-22 2013-10-30 Lieur glycosylé, composé contenant un fragment de lieur glycosylé et un fragment de substance physiologiquement active ou son sel et procédés de production dudit composé ou de son sel

Publications (1)

Publication Number Publication Date
DK2924053T3 true DK2924053T3 (da) 2020-12-14

Family

ID=50775917

Family Applications (1)

Application Number Title Priority Date Filing Date
DK13857593.1T DK2924053T3 (da) 2012-11-22 2013-10-30 Glycosyleret linker, forbindelse, der indeholder glycosyleret linker-del og fysiologisk aktiv stofdel eller salt deraf, og fremgangsmåder til fremstilling af forbindelsen eller saltet deraf

Country Status (8)

Country Link
US (1) US9708413B2 (fr)
EP (1) EP2924053B1 (fr)
JP (1) JP6211533B2 (fr)
KR (1) KR102227918B1 (fr)
CN (1) CN104918962B (fr)
DK (1) DK2924053T3 (fr)
TW (1) TWI634127B (fr)
WO (1) WO2014080730A1 (fr)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN107029242A (zh) 2015-11-03 2017-08-11 财团法人工业技术研究院 抗体药物复合物及其制造方法
CN112154158A (zh) * 2018-03-22 2020-12-29 持田制药株式会社 连接有非甾体抗炎化合物的海藻酸衍生物
JP7437578B2 (ja) * 2019-03-20 2024-02-26 国立大学法人東北大学 新規オピオイドペプチド、その糖鎖付加体及びそれらを含む医薬組成物
CN113501889A (zh) * 2021-07-06 2021-10-15 郑州大学 一种三七多糖阳离子衍生物的制备方法及其应用

Family Cites Families (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0778081B2 (ja) * 1990-07-19 1995-08-23 静岡大学長 機能化高分子の合成方法
JP2604930B2 (ja) * 1990-12-14 1997-04-30 株式会社ディ・ディ・エス研究所 ヒアルロン酸およびコンドロイチン誘導体
JP2527885B2 (ja) * 1992-09-02 1996-08-28 株式会社ディ・ディ・エス研究所 ヘパリン誘導体
ATE199908T1 (de) * 1996-12-16 2001-04-15 Nederlanden Staat Verfahren zur kupplung von polysacchariden und proteinen
JP2001302695A (ja) 2000-04-20 2001-10-31 Asahi Kasei Corp Ｇｌｎ結合型糖鎖付加カルシトニン誘導体
US6441293B1 (en) 2000-04-28 2002-08-27 Labarbera Anthony System for generating percussion sounds from stringed instruments
CA2451971C (fr) 2001-06-19 2010-09-07 Otsuka Chemical Co., Ltd. Methode de production d'un derive d'asparagine de chaines des sucres
US20030096299A1 (en) 2001-07-09 2003-05-22 Valerie Wittamer Natural ligand of G protein coupled receptor ChemR23 and uses thereof
US7943763B2 (en) 2002-07-05 2011-05-17 Otsuka Chemical Holdings Co., Ltd. Process for preparing glycopeptides having asparagine-linked oligosaccharides, and the glycopeptides
TWI335920B (en) 2002-12-24 2011-01-11 Yasuhiro Kajihara Sugar chain asparagine derivatives, sugar chain asparagine and sugar chain and manufacture thereof
AU2003292641B2 (en) 2002-12-26 2007-11-29 Glytech, Inc. Three-branched sugar-chain asparagine derivatives, the sugar-chain asparagines, the sugar chains, and processes for producing these
ES2701175T3 (es) 2003-02-04 2019-02-21 Glytech Inc Proceso para producir derivado de asparagina de cadena de azúcar
PL1620118T3 (pl) 2003-04-08 2014-11-28 Yeda Res & Dev Leki odwracalnie pegylowane
DE602004012269T2 (de) * 2003-07-11 2009-04-30 Theravance, Inc., South San Francisco Quervernetzte glycopeptid-cephalosporin-antibiotika
WO2005007694A1 (fr) 2003-07-16 2005-01-27 Green Peptide Co., Ltd. Peptide her2/neu et utilisation therapeutique de celui-ci
CA2533849C (fr) 2003-07-28 2013-07-02 Otsuka Chemical Co., Ltd. Derives amines a chaine de sucre de type complexe et procede de realisation associe
PL1660134T3 (pl) * 2003-08-08 2011-05-31 Fresenius Kabi Deutschland Gmbh Koniugaty hydroksyalkiloskrobi i G-CSF
JP2007501870A (ja) * 2003-08-08 2007-02-01 フレゼニウス・カビ・ドイチュラント・ゲゼルシャフト・ミット・ベシュレンクテル・ハフツング ヒドロキシアルキルデンプンとｇ−ｃｓｆの複合体
CN1310898C (zh) * 2004-01-19 2007-04-18 中国人民解放军军事医学科学院毒物药物研究所 紫杉醇水溶性衍生物
AU2005229001A1 (en) 2004-03-23 2005-10-13 Amgen Inc. Chemically modified protein compositions and methods
JPWO2005095331A1 (ja) 2004-03-31 2008-02-21 塩野義製薬株式会社 糖鎖−ペプチド結合剤
TW200643033A (en) * 2005-03-08 2006-12-16 Chugai Pharmaceutical Co Ltd Conjugate of water-soluble modified hyaluronic acid and glp-1 analogue
TWI342880B (en) 2005-07-19 2011-06-01 Otsuka Chemical Co Ltd Method for producing sugar chain derivatives, and sugar chain derivatives
KR20100049032A (ko) * 2007-06-19 2010-05-11 오츠카 가가쿠 가부시키가이샤 당사슬 부가 ｇｌｐ―１ 펩티드
AU2009209565B2 (en) * 2008-02-01 2013-09-19 Ascendis Pharma As Prodrug comprising a self-cleavable linker
JP2009242372A (ja) 2008-03-11 2009-10-22 Yokohama City Univ 均一な糖鎖構造を有するエリスロポエチン誘導体
US8765669B2 (en) 2008-06-17 2014-07-01 Glytech, Inc. Glycosylated GLP-1 peptide
HUE037238T2 (hu) 2008-08-19 2018-08-28 Glytech Inc Glikoprotein elõállítási eljárás és screening eljárás
JP2010229093A (ja) 2009-03-27 2010-10-14 Banyu Pharmaceut Co Ltd 新規ＣｈｅｍｅｒｉｎＲアゴニスト
KR20120101037A (ko) * 2009-10-30 2012-09-12 오츠카 가가쿠 가부시키가이샤 항원성 ｇｌｐ?１ 아날로그의 당쇄 부가체

Also Published As

Publication number Publication date
JP6211533B2 (ja) 2017-10-11
CN104918962A (zh) 2015-09-16
EP2924053A1 (fr) 2015-09-30
US20150299337A1 (en) 2015-10-22
US9708413B2 (en) 2017-07-18
JPWO2014080730A1 (ja) 2017-01-05
KR102227918B1 (ko) 2021-03-15
TWI634127B (zh) 2018-09-01
TW201427999A (zh) 2014-07-16
EP2924053B1 (fr) 2020-11-11
CN104918962B (zh) 2017-12-19
EP2924053A4 (fr) 2016-08-24
WO2014080730A1 (fr) 2014-05-30
KR20150102003A (ko) 2015-09-04

Similar Documents

Publication Publication Date Title
IL275998B (en) Medical system
IL276729A (en) Methods, compositions, and devices for supplying dietary fatty acid needs
NO2018026I2 (no) Bictegravir eller et farmasøytisk akseptabelt salt derav, spesielt natriumbictegravir
IL233663B (en) Indolizine compounds, processes for their preparation and pharmaceutical compositions containing them
DK2900752T3 (da) Fugemasse, vægenhed og fremgangsmåder og produkter relateret dertil
DK2934189T3 (da) Humane mælkeoligosaccharider til reduktion af stress-symptomer
DK2723887T3 (da) Systemer, fremgangsmåder og indretinger til at opnå glykæmisk ligevægt
EP2916905A4 (fr) Raccord médical
EP2842540A4 (fr) Raccord médical
DK2841429T3 (da) Tetrazolinonforbindelser og anvendelse deraf som pesticider
DK2611785T3 (da) N-(tetrazol-5yl)- og n- (triazol-5-yl) arylcarboxylsyreamider og deres anvendelse som herbicider
CO7061071A2 (es) Procesos para la preparación de (s)-1-(3-etoxi-4-metoxifenil)-2-metansulfoniletilamina
EP2680775A4 (fr) Système médical cryogénique
IL232035A0 (en) Heterocyclic compounds, medicaments containing said compounds, use thereof and processes for the preparation thereof
EP2731594A4 (fr) Préparation sous forme de capsule comprenant du montélukast et de la lévocétirizine
DK2809318T3 (da) Ammoniumholdige sulfonsyre-, phosphonsyre- og carboxylsyrederivater og disses medicinske anvendelse
IL231444A0 (en) Aniline derivativs, their preparation and their therapeutic application
DK2920240T3 (da) Fremgangsmåde til fremstilling af en vandig opløsning af chitosan, chitosansammensætning, chitosanaerosol, fremgangsmåde til fremstilling af en chitosanhydrogelmembran og fremgangsmåde til fremstilling af et chitosan-protein-biopolymermateriale
EP2771213A4 (fr) Système de sauvetage assisté
DK2736888T3 (da) 3-heteroaroylaminopropionsyrederivater og deres anvendelse som farmaceutika
CU20130003A7 (es) Procedimiento de preparacion de la sal de l-arginina de perindoprilo.
HRP20260138T1 (hr) Postupak priprave 2,3,3,3-tetrafluoropropena
DK2812440T3 (da) Fremgangsmåde til fremstilling af furanderivater af glucose
DK2871184T3 (da) Benzodioxolderivat og fremgangsmåde til fremstilling og anvendelse deraf
DK2882863T3 (da) System og fremgangsmåde til kvantitativ billeddannelse af mitokondriekompleks 1